GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture
University Medical Center Utrecht · Royal College of Surgeons in Ireland · +201 more institutions
Abstract
Epilepsy is a highly heritable disorder affecting over 50 million people worldwide, of which about one-third are resistant to current treatments. Here we report a multi-ancestry genome-wide association study including 29,944 cases, stratified into three broad categories and seven subtypes of epilepsy, and 52,538 controls. We identify 26 genome-wide significant loci, 19 of which are specific to genetic generalized epilepsy (GGE). We implicate 29 likely causal genes underlying these 26 loci. SNP-based heritability analyses show that common variants explain between 39.6% and 90% of genetic risk for GGE and its subtypes. Subtype analysis revealed markedly different genetic architectures between focal and…
Citation impact
- FWCI
- 60.81
- Percentile
- 100%
- References
- 110
Authors
319- RSRemi StevelinkCorresponding
University Medical Center Utrecht
- CCCiarán Campbell
Royal College of Surgeons in Ireland
- SCSiwei Chen
Broad Institute, Harvard University, Massachusetts General Hospital
- BABassel Abou‐Khalil
Vanderbilt University Medical Center
- OMOluyomi M. Adesoji
University of Cologne, University Hospital Cologne
Topics & keywords
- Genetic architecture
- Genome-wide association study
- Biology
- Epilepsy
- Genetics
- Heritability
- Genetic association
- SNP
- Good health and well-being
Funding
- CACooley's Anemia Foundation
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- NNovartisAward: FP7/2007-2013
- SSanofi
- MGMassachusetts General Hospital
- BBiogen
- CCelgene
- WTWellcome TrustAwards: 084730, 203914/Z/16/, FP7/2007-2013, 203914/Z/16/Z
- BIBroad InstituteAwards: UM1 HG008895, 5U01HG009088, 5U01HG009088-02
- URUK Research and Innovation
- AGAustralian Government
- MTMaze Therapeutics
- NINational Institute for Health and Care ResearchAwards: 203914/Z/16/Z, FP7/2007-2013
- UCUniversity College London
- ECEuropean CommissionAwards: FP7/2007-2013, 2007-2013, FP7/2007, 279062
- SFScience Foundation IrelandAward: 16/RC/3948
- DFDeutsche ForschungsgemeinschaftAwards: UM1 HG008895, FP7/2007-2013, FOR-2715, 5U01HG009088-02
- UOUniversity of Melbourne
- FDFundação de Amparo à Pesquisa do Estado de São PauloAward: 2013/07559-3
- FNFonds National de la Recherche LuxembourgAwards: UM1 HG008895, 5U01HG009088-02
- AOAcademy of Finland
- BFBusiness FinlandAwards: 4685/31/2016, UH 4386/31/2016, HUS 4685/31/2016 and UH 4386/31/2016, HUS 4685/31/2016
- ESEpilepsy Society
- NINational Institutes of HealthAwards: HG008895, FP7/2007-2013, 5U01HG009088-02
- GGenentech
- SCStanley Center for Psychiatric Research, Broad Institute
- MRMedical Research CouncilAwards: MR/S02638X/1, 203914/Z/16/Z, MR/S02638X/1
- NHNational Health and Medical Research CouncilAwards: APP533086, APP1195236, 1091593
- EREuropean Regional Development FundAwards: 2007-2013, FP7/2007-2013, 16/RC/3948
- NHNational Heart, Lung, and Blood InstituteAwards: UM1 HG008895, 5U01HG009088-02
- NHNational Human Genome Research InstituteAwards: 5U01HG009088, HG008895, 5U01HG009088-02, UM1 HG008895
- NINational Institute of Diabetes and Digestive and Kidney Diseases
- NINational Institute of Child Health and Human Development
- JBJanssen Biotech
- EKEunice Kennedy Shriver National Institute of Child Health and Human Development